ライフサイエンスコーパス: exposure history

1 ect on the outcome of infection depending on exposure history.

2 epertoire dynamically encodes their pathogen exposure history.

3 menopausal status, smoking habit, and sexual exposure history.

4 background groundwater with no known dioxane exposure history.

5 mately allows cells to determine their light exposure history.

6 ects genetic background and/or environmental exposure history.

7 , and detailed occupational and occupational exposure history.

8 r site were investigated which had different exposure histories.

9 nsity change differ for women with different exposure histories.

10 Among the 7 patients with a definite exposure history, 6 cases were attributable to dog bites

11 Evaluation included a medical and drug exposure history, a physical examination, a chest x-ray

12 They also suggest that exposure history affects the cross-reactivity of vaccina

13 h cases, microbial community composition and exposure history alter the influence of triclosan.

14 uld provide the means to reconstruct hypoxia exposure histories and major patterns of fish movement n

15 Exposure histories and molecular analysis of HPIV3 isola

16 tyle patterns, dietary habits, environmental exposure history and long-term health outcomes of 300,00

17 t was attributed to MERS-CoV on the basis of exposure history and positive results of MERS-CoV serolo

18 ence is accumulating of associations between exposure history and primary MDS.

19 concentrations by "remembering" their ligand exposure history and relative direction.

20 We collected data on exposure history and symptoms, did a complete medical an

21 nteractions among psychiatric symptoms, drug exposure history, and addiction vulnerability.

22 Information on demographic characteristics, exposure history, and illness timelines was obtained fro

23 a proxy exposure measurement, uncertain work exposure history, and laboratory or other errors.

24 patient clinical data, including antibiotic exposure history, and whole-genome sequencing and phylog

25 sonal interview appear to reflect a person's exposure history based on histologic evidence.

26 iffered only as a function of their previous exposure history; CS+ stimuli were initially paired with

27 we analyzed demographic and HCV risk factor exposure history data from 3,871 patients, including 1,9

28 ach new light level is affected by the light exposure history experienced during previous steps of th

29 cancer, both cigarette smoking and asbestos exposure histories favor an upper-lobe location of tumor

30 Exposure histories for controls were censored 6 months b

31 In such studies, the exposure history for controls consists of the number of

32 airborne analytes in a matrix to provide an exposure history for off-site analysis.

33 ransmission seasonality, treatment level and exposure history, from which we predict accelerating ret

34 diagnosis, independently of any knowledge of exposure history, identified 75 cytogenetically abnormal

35 gulate the outcome of infection depending on exposure history.IMPORTANCE The impact of hormone-based

36 By examining environmental exposure history in cervical dystonia patients and their

37 ed from three individuals residing or having exposure history in Minnesota or Wisconsin, and similarl

38 epends on the metal composition, its tritium exposure history, integrated neutron flux, sample size,

39 Our results demonstrate that Omegaar exposure history largely determines pteropod response to

40 often used, combining strata with identical exposure histories may be computationally convenient.

41 Clinical outcome and juice exposure histories of case-patients, pulsed-field gel el

42 The exposure history of cases and controls to non-natural U

43 We reviewed the exposure history of reported cases of Lyme disease and p

44 We collected clinical and exposure history of the case patients and monitored pers

45 Exposure history of YAHL case-twins was compared with th

46 mpensation, whereas age at entry and initial exposure, history of transfusion, lower initial levels o

47 Thus, we find no impacts of OA exposure history on CCRA provision of settlement cues.

48 ponses to particular aspects of the paternal exposure history, or a generic response to paternal 'qua

49 A thorough exposure history, particularly for tick bites, and aware

50 nt extensive evaluation of their medical and exposure history, physical examination, pulmonary-functi

51 e results were not influenced by neuroleptic exposure history, postmortem interval, or age of the sub

52 Analyses that examined exposure history provided additional evidence for the ca

53 re reviewed for demographic characteristics, exposure history, rabies prophylaxis, clinical presentat

54 Host genetics and pre-exposure history shape norovirus vaccine Ab responses, i

55 health behaviors, socioeconomic status, sun-exposure history, skin sensitivity to sunlight, and deta

56 ible measures of individual longitudinal sun exposure history, stable personal characteristics, ambie

57 e color; skin cancer family history; and sun exposure history, such as tanning ability and number of

58 Demographics, dust exposure history, symptoms, spirometry, exhaled nitric o

59 Existing instruments to capture sun exposure history tend to yield reproducible results, but

60 Humans have complex influenza exposure histories that increase with age, which may lea

61 -person interview ascertained light-at-night exposure histories through shift work (previous 15 years

62 cancer demonstrated that reducing a complex exposure history to a metric such as cumulative exposure

63 nst non-GII.4 VLPs, suggesting that previous exposure history to this dominant circulating genotype m

64 ol study of bladder cancer in which detailed exposure histories were available on all 230 cases and 2

65 Detailed exposure histories were obtained by interview.

66 an donor were identified, their clinical and exposure histories were reviewed, and samples were obtai

67 t the importance of considering clinical and exposure history when interpreting laboratory results fo

68 highlight the necessity of considering drug exposure history when selecting control groups for genet